© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
Author | Dimitrios Bafaloukos, MD
Articles
Paclitaxel and Carboplatin as First-Line Chemotherapy for Advanced Breast Cancer
January 01, 1998
ByGeorge Fountzilas, MD|Dimitrios Bafaloukos, MD|Gerasimos Aravantinos, MD|Constantine Nicolaides, MD|Haralambos Kalofonos, MD|Pavlos Papakostas, MD|Nicholaos Xiros, MD|Evalgelia Razi, MDIn a phase II study, 66 patients with advanced breast cancer (median age 56 years; range, 28 to 75 years) were treated with paclitaxel (Taxol), 175 mg/m² infused over 3 hours, and carboplatin (Paraplatin), dosed to attain an